Clearside Biomedical Inc reports results for the quarter ended in December - Earnings Summary

Clearside Biomedical,

10/03/2022 23:37

* Clearside Biomedical Inc  CLSD.OQ  reported quarterly
adjusted
earnings of 31 cents​​ per share for the quarter ended in
December. The mean expectation of six analysts for the quarter
was for earnings of 16 cents per share.
    * Revenue rose 233,418.2% to $25.69 million from a year
ago; 
analysts expected $17.77 million. 
    * Clearside Biomedical Inc's reported EPS for the quarter
was 31
cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Clearside Biomedical Inc shares had fallen by 45.8% this
quarter.
    * The company reported quarterly net income of $18.71
million.
    * Wall Street's median 12-month price target for Clearside
Biomedical Inc is $10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 10 at 11:37 p.m.  ​All
figures in US dollars unless otherwise stated